C OSBORNE's research topics

C OSBORNE

Concepts (714)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Tamoxifen	74	2011	876	4.530	Why?
Receptors, Estrogen	114	2015	2086	4.430	Why?
Breast Neoplasms	248	2015	15694	4.030	Why?
Antineoplastic Agents, Hormonal	48	2011	840	3.790	Why?
Poaceae	6	2023	11	1.980	Why?
Receptors, Progesterone	46	2012	1392	1.850	Why?
Estrogen Antagonists	23	2011	184	1.810	Why?
Neoplasms, Hormone-Dependent	19	2011	342	1.440	Why?
Photosynthesis	4	2023	13	1.430	Why?
Estradiol	22	2010	748	1.290	Why?
Receptor, ErbB-2	24	2015	2518	1.170	Why?
Estrogen Receptor Modulators	10	2005	112	0.930	Why?
Drug Resistance, Neoplasm	24	2011	5178	0.890	Why?
Quinazolines	7	2015	923	0.840	Why?
Antineoplastic Combined Chemotherapy Protocols	48	2015	15862	0.800	Why?
Selective Estrogen Receptor Modulators	7	2010	145	0.800	Why?
Growth Substances	9	2004	300	0.800	Why?
Aromatase Inhibitors	10	2015	305	0.750	Why?
Biomarkers, Tumor	30	2013	10331	0.720	Why?
Plant Leaves	4	2023	61	0.650	Why?
Estrogens	19	2006	751	0.640	Why?
DNA, Neoplasm	18	2013	1910	0.630	Why?
Gene Transfer, Horizontal	2	2019	57	0.600	Why?
Receptor Cross-Talk	5	2011	79	0.590	Why?
Water	2	2021	361	0.580	Why?
Female	214	2015	141928	0.580	Why?
Cyclophosphamide	34	2011	3001	0.560	Why?
Droughts	2	2021	11	0.540	Why?
Carbon Dioxide	2	2014	313	0.540	Why?
Receptors, Growth Factor	3	2005	157	0.540	Why?
Cell Division	35	2003	2489	0.530	Why?
Antibodies, Monoclonal, Humanized	5	2015	3251	0.520	Why?
Plant Proteins	2	2013	133	0.520	Why?
Nitriles	8	2015	906	0.500	Why?
Genes, Plant	2	2019	44	0.490	Why?
Antineoplastic Agents	25	2015	14289	0.480	Why?
Humans	264	2015	261506	0.470	Why?
ErbB Receptors	16	2011	2295	0.460	Why?
Chemotherapy, Adjuvant	25	2010	3890	0.450	Why?
Fluorouracil	29	2010	1944	0.450	Why?
Triazoles	8	2015	617	0.440	Why?
Mucin-1	1	2013	127	0.440	Why?
Evolution, Molecular	3	2019	834	0.430	Why?
Doxorubicin	22	2011	3005	0.430	Why?
Tumor Cells, Cultured	28	2003	5395	0.420	Why?
Insulin-Like Growth Factor I	10	2006	630	0.410	Why?
Gene Expression Regulation, Neoplastic	22	2009	8873	0.400	Why?
Neoplasm Metastasis	21	2013	5112	0.390	Why?
Estrogen Receptor alpha	6	2008	701	0.390	Why?
Drug Resistance	14	2005	587	0.390	Why?
Lymphatic Metastasis	34	2009	4844	0.370	Why?
Pregnancy Complications, Neoplastic	1	2011	222	0.360	Why?
Methotrexate	23	2010	999	0.340	Why?
Receptors, Cell Surface	11	1995	862	0.330	Why?
Heat-Shock Proteins	5	2011	311	0.330	Why?
Climate Change	2	2021	32	0.310	Why?
Ovariectomy	5	1998	330	0.310	Why?
Carcinoma	4	2015	2578	0.310	Why?
Prednisone	17	2011	984	0.310	Why?
Mice, Nude	24	2008	4307	0.300	Why?
Sirolimus	1	2012	814	0.300	Why?
Somatomedins	4	1999	75	0.300	Why?
Signal Transduction	21	2011	11965	0.300	Why?
Disease-Free Survival	30	2010	10001	0.300	Why?
Prognosis	58	2012	21713	0.290	Why?
Repressor Proteins	6	2005	1664	0.280	Why?
Clinical Trials as Topic	16	2011	3719	0.280	Why?
Postmenopause	11	2009	378	0.270	Why?
Immunosuppressive Agents	1	2012	1375	0.260	Why?
Ploidies	10	2000	248	0.260	Why?
Genes, erbB-1	1	2005	101	0.260	Why?
Middle Aged	85	2011	86204	0.250	Why?
Vincristine	12	2011	1511	0.250	Why?
Gene Expression Profiling	7	2009	5159	0.250	Why?
Lymphoma	4	2011	1467	0.240	Why?
Immunohistochemistry	16	2010	7548	0.240	Why?
Aged	67	2011	70117	0.240	Why?
Goserelin	3	2005	18	0.230	Why?
Epidermal Growth Factor	6	2004	423	0.230	Why?
Transcription Factor AP-1	2	2002	246	0.230	Why?
Antibiotics, Antineoplastic	5	2009	726	0.230	Why?
Adult	71	2011	77950	0.230	Why?
Proportional Hazards Models	13	2009	4988	0.230	Why?
Trastuzumab	4	2015	696	0.220	Why?
Transcription Factors	6	2003	5270	0.220	Why?
Survival Analysis	23	2007	9180	0.220	Why?
Mitogen-Activated Protein Kinases	3	2003	639	0.220	Why?
Nuclear Proteins	7	2005	3343	0.210	Why?
Receptors, Retinoic Acid	2	2003	365	0.210	Why?
Insulin-Like Growth Factor II	3	1992	107	0.210	Why?
Mammary Neoplasms, Experimental	5	1999	494	0.210	Why?
Lymph Nodes	15	2009	2967	0.200	Why?
Xylem	1	2021	3	0.200	Why?
Transforming Growth Factor alpha	4	1994	95	0.200	Why?
Plants	1	2021	62	0.200	Why?
Transforming Growth Factors	5	1988	40	0.200	Why?
Acclimatization	1	2021	42	0.200	Why?
Genetic Markers	1	2003	974	0.190	Why?
Cell Line	22	2003	5114	0.190	Why?
Biological Evolution	3	2023	278	0.190	Why?
Computer Simulation	1	2006	1529	0.190	Why?
Animals	53	2008	59536	0.180	Why?
Enzyme Inhibitors	5	2004	1879	0.180	Why?
HSP70 Heat-Shock Proteins	2	1998	161	0.180	Why?
Mitoxantrone	7	1999	216	0.170	Why?
Genes, erbB-2	3	2011	229	0.170	Why?
Aged, 80 and over	24	2011	29902	0.170	Why?
Adenocarcinoma	9	2009	7789	0.170	Why?
Antineoplastic Agents, Phytogenic	4	2005	852	0.170	Why?
Matrix Attachment Region Binding Proteins	3	2005	23	0.160	Why?
Nuclear Matrix-Associated Proteins	3	2005	33	0.160	Why?
Trans-Activators	3	2005	1555	0.160	Why?
Menopause	10	2003	159	0.150	Why?
Drug Administration Schedule	12	2007	3472	0.150	Why?
Neoplasms, Experimental	6	1989	750	0.150	Why?
Predictive Value of Tests	14	2010	4892	0.150	Why?
Phenotype	6	2021	6295	0.150	Why?
Polymorphism, Genetic	4	2010	1450	0.150	Why?
Mice	35	2008	34495	0.150	Why?
Transfection	9	2002	2944	0.150	Why?
Treatment Outcome	28	2011	32848	0.150	Why?
S Phase	8	2000	281	0.150	Why?
Mesoderm	1	2009	404	0.150	Why?
Proto-Oncogene Proteins c-bcl-2	4	1998	1493	0.150	Why?
Cathepsin D	2	1994	32	0.150	Why?
Databases, Factual	2	2021	2218	0.150	Why?
Antibodies, Monoclonal	10	2011	4367	0.150	Why?
Taxoids	3	2005	967	0.150	Why?
Neoplasm Transplantation	9	2006	1519	0.140	Why?
Tetrahydronaphthalenes	2	2010	116	0.140	Why?
Drug Evaluation	8	1992	425	0.140	Why?
Neoplasms, Second Primary	1	2005	1350	0.140	Why?
Melphalan	4	2003	834	0.140	Why?
Peptides	5	1988	1479	0.140	Why?
Receptors, Steroid	4	1992	286	0.140	Why?
Neoplasm Proteins	8	2000	3230	0.130	Why?
Carcinoma, Ductal, Breast	4	2010	1216	0.130	Why?
Transplantation, Heterologous	8	2006	1082	0.130	Why?
Combined Modality Therapy	17	2005	8865	0.130	Why?
Anticarcinogenic Agents	2	2010	362	0.130	Why?
Double-Blind Method	7	2010	2588	0.130	Why?
Hematopoietic Cell Growth Factors	2	1991	38	0.130	Why?
Recombinant Fusion Proteins	4	2000	1555	0.130	Why?
Superoxide Dismutase	2	2010	266	0.130	Why?
Megestrol	2	1997	15	0.130	Why?
Hormones	5	1989	266	0.130	Why?
Receptors, Somatomedin	6	1999	70	0.120	Why?
Phylogeny	2	2019	826	0.120	Why?
Plant Stomata	1	2014	10	0.120	Why?
Loss of Heterozygosity	3	2001	602	0.120	Why?
Cell Proliferation	6	2011	7226	0.120	Why?
Oxidative Stress	1	2000	1129	0.120	Why?
South Africa	1	2014	92	0.120	Why?
Tumor Suppressor Protein p53	6	1998	3552	0.120	Why?
Prostatic Neoplasms	5	1992	5767	0.120	Why?
Nursing Assessment	1	1993	42	0.120	Why?
Multivariate Analysis	7	2004	4298	0.120	Why?
Transcriptome	2	2013	1859	0.120	Why?
Time Factors	18	2010	12926	0.120	Why?
Immunotoxins	1	1994	117	0.110	Why?
Neoplasm, Residual	1	2009	1656	0.110	Why?
Carbon	1	2014	149	0.110	Why?
Insulin	7	1984	1454	0.110	Why?
Orientation	1	1993	57	0.110	Why?
Axilla	10	2005	902	0.110	Why?
Premenopause	5	2005	131	0.110	Why?
Survival Rate	15	2005	12221	0.110	Why?
Dose-Response Relationship, Drug	8	2007	4938	0.110	Why?
Disease Progression	11	2011	6682	0.110	Why?
Air	1	2013	63	0.110	Why?
Kinetics	10	1990	2049	0.110	Why?
Nurses	1	1993	80	0.110	Why?
Pyrrolidines	2	2010	113	0.110	Why?
Flow Cytometry	9	1999	3033	0.110	Why?
Granulocyte-Macrophage Colony-Stimulating Factor	1	1994	408	0.110	Why?
Tyrphostins	1	1992	107	0.100	Why?
Research Personnel	1	1993	156	0.100	Why?
Blotting, Western	5	2003	3536	0.100	Why?
Sequence Analysis, Protein	1	2012	81	0.100	Why?
Phosphotransferases	1	1992	84	0.100	Why?
Neutropenia	2	2010	968	0.100	Why?
Polymerase Chain Reaction	4	2009	3203	0.100	Why?
Vinblastine	2	2011	453	0.100	Why?
Data Collection	2	1993	620	0.100	Why?
Histone Acetyltransferases	2	2003	411	0.100	Why?
Histone Deacetylases	2	2005	365	0.100	Why?
Receptor, IGF Type 1	4	2011	347	0.100	Why?
Phosphotransferases (Alcohol Group Acceptor)	1	1992	129	0.100	Why?
Molecular Targeted Therapy	2	2011	2330	0.100	Why?
Phosphorylation	9	2008	4804	0.100	Why?
Neoplasm Invasiveness	6	2010	3981	0.100	Why?
Plasmids	2	2002	837	0.100	Why?
Osteoporosis, Postmenopausal	1	2010	37	0.100	Why?
Proto-Oncogene Proteins	4	1994	2488	0.100	Why?
Gene Amplification	3	2011	731	0.100	Why?
Analysis of Variance	6	1997	2307	0.090	Why?
Logistic Models	5	2010	3441	0.090	Why?
Bleomycin	1	2011	467	0.090	Why?
Activities of Daily Living	1	1993	552	0.090	Why?
Women's Health	1	2012	205	0.090	Why?
Health Planning Guidelines	1	2010	58	0.090	Why?
Nuclear Receptor Coactivator 3	2	2003	383	0.090	Why?
Southwestern United States	3	2010	62	0.090	Why?
Motivation	1	1993	499	0.090	Why?
Sequence Alignment	1	2012	844	0.090	Why?
Placebos	1	2011	437	0.090	Why?
Forecasting	3	2005	694	0.090	Why?
Mice, Inbred BALB C	7	2004	2314	0.090	Why?
Phosphoproteins	3	2001	1152	0.090	Why?
Genetic Vectors	2	1994	1694	0.090	Why?
Fertility Preservation	1	2011	150	0.090	Why?
Everolimus	1	2012	415	0.090	Why?
Gene Expression	5	2002	3570	0.090	Why?
Dacarbazine	1	2011	485	0.090	Why?
Acronine	1	1989	1	0.090	Why?
Protein-Tyrosine Kinases	3	2011	1756	0.090	Why?
Peroxidase	1	2009	132	0.090	Why?
Antibodies, Monoclonal, Murine-Derived	1	2011	864	0.080	Why?
Alkaloids	1	1989	75	0.080	Why?
Metabolic Networks and Pathways	1	2010	336	0.080	Why?
Molecular Sequence Data	5	2012	6089	0.080	Why?
Nuclear Receptor Co-Repressor 1	3	2005	71	0.080	Why?
Nitric Oxide Synthase Type III	1	2009	265	0.080	Why?
Genes, Tumor Suppressor	3	2001	1064	0.080	Why?
Promoter Regions, Genetic	5	2006	3101	0.080	Why?
Antineoplastic Agents, Alkylating	3	2010	588	0.080	Why?
Pregnancy Outcome	1	2011	643	0.080	Why?
Guidelines as Topic	1	2010	383	0.080	Why?
Fractures, Bone	1	2010	291	0.080	Why?
Amino Acid Sequence	3	2012	4233	0.080	Why?
Binding, Competitive	3	2000	300	0.080	Why?
Anthraquinones	2	1985	27	0.080	Why?
Chromatography, High Pressure Liquid	4	1994	548	0.080	Why?
Cell Cycle	7	2006	2084	0.070	Why?
North America	2	2010	314	0.070	Why?
Estrogen Receptor beta	2	2004	155	0.070	Why?
Attitude of Health Personnel	1	1993	918	0.070	Why?
Treatment Failure	4	2010	1391	0.070	Why?
Ki-67 Antigen	3	2000	666	0.070	Why?
Mastectomy	7	2005	1534	0.070	Why?
Receptors, Interleukin	1	2006	97	0.070	Why?
Rituximab	1	2011	1528	0.070	Why?
Quality of Life	4	2002	4532	0.070	Why?
Receptors, Somatotropin	1	2006	17	0.070	Why?
Cytosol	3	1997	238	0.070	Why?
Drug Screening Assays, Antitumor	3	1994	566	0.070	Why?
Transcription, Genetic	3	2008	3154	0.070	Why?
Medroxyprogesterone	2	1985	14	0.070	Why?
Tumor Necrosis Factor-alpha	1	1991	1538	0.070	Why?
United States	12	2010	15433	0.070	Why?
Human Growth Hormone	1	2006	82	0.070	Why?
DNA	4	2006	2693	0.070	Why?
Anthracenes	6	1991	48	0.070	Why?
Drug-Related Side Effects and Adverse Reactions	1	2011	598	0.070	Why?
Biopsy, Needle	5	2005	1363	0.070	Why?
Transcriptional Activation	2	2000	1070	0.070	Why?
Immunologic Factors	1	1989	649	0.070	Why?
Glutathione Transferase	2	2010	359	0.070	Why?
Pyridines	1	1992	1244	0.070	Why?
Ligands	4	2004	995	0.070	Why?
Mastectomy, Radical	3	2003	39	0.060	Why?
Follow-Up Studies	10	2007	14889	0.060	Why?
Cell Nucleus	5	2000	1620	0.060	Why?
Colony-Forming Units Assay	1	1985	249	0.060	Why?
Tumor Stem Cell Assay	1	1985	231	0.060	Why?
Models, Biological	4	2009	3254	0.060	Why?
Dog Diseases	1	2005	73	0.060	Why?
Insulin-Like Growth Factor Binding Proteins	2	1997	60	0.060	Why?
Protein Binding	5	2004	3438	0.060	Why?
Proteinuria	1	2005	155	0.060	Why?
Neoplasm Recurrence, Local	10	2010	10035	0.060	Why?
Paclitaxel	2	2003	1996	0.060	Why?
Drug Approval	1	2005	178	0.060	Why?
Biopsy	7	2009	3443	0.060	Why?
Injections, Intramuscular	1	2004	255	0.060	Why?
Androstenedione	1	2003	18	0.060	Why?
p38 Mitogen-Activated Protein Kinases	1	2005	334	0.060	Why?
Cell Size	1	2023	136	0.060	Why?
Metallothionein	2	1994	34	0.060	Why?
DNA-Binding Proteins	4	2000	4821	0.060	Why?
JNK Mitogen-Activated Protein Kinases	2	2002	301	0.060	Why?
Oligonucleotide Array Sequence Analysis	4	2008	2508	0.060	Why?
Disease Models, Animal	5	2000	7222	0.060	Why?
Pain Management	1	1989	668	0.060	Why?
Decision Making	2	2003	1287	0.060	Why?
Nuclear Receptor Coactivator 1	1	2003	236	0.050	Why?
Creatinine	1	2005	531	0.050	Why?
Oncogene Proteins, Viral	2	1994	133	0.050	Why?
In Situ Hybridization	2	1995	1037	0.050	Why?
Acetyltransferases	1	2003	143	0.050	Why?
Genes, Dominant	1	2003	331	0.050	Why?
Carrier Proteins	1	1990	2022	0.050	Why?
Bone Density	2	2010	476	0.050	Why?
Plant Physiological Phenomena	1	2021	7	0.050	Why?
Stereoisomerism	2	1992	164	0.050	Why?
Hyperbaric Oxygenation	2	1973	48	0.050	Why?
Phorbols	1	1981	9	0.050	Why?
Chromosomes, Human, Pair 14	2	2001	272	0.050	Why?
Cell Line, Tumor	8	2006	14551	0.050	Why?
Structure-Activity Relationship	2	2000	931	0.050	Why?
Nucleoside-Diphosphate Kinase	1	2001	13	0.050	Why?
Radioimmunoassay	2	1991	191	0.050	Why?
RNA, Neoplasm	4	1990	771	0.050	Why?
Climate	1	2021	23	0.050	Why?
Statistics as Topic	3	1999	445	0.050	Why?
Genetic Testing	1	2009	1589	0.050	Why?
Phorbol Esters	1	1981	39	0.050	Why?
Biophysical Phenomena	1	2021	112	0.050	Why?
Benzamides	1	2006	1832	0.050	Why?
Australia	1	2021	225	0.050	Why?
Monomeric GTP-Binding Proteins	1	2001	43	0.050	Why?
Apoptosis	4	2005	7591	0.050	Why?
Chloramphenicol O-Acetyltransferase	1	2000	118	0.050	Why?
Research	3	1995	415	0.050	Why?
Oncogene Proteins	1	2003	354	0.050	Why?
Infusions, Intravenous	3	2007	1382	0.050	Why?
Clinical Trials, Phase III as Topic	3	2009	447	0.050	Why?
Homeodomain Proteins	1	2006	1143	0.050	Why?
Cold Temperature	1	2021	121	0.050	Why?
Prospective Studies	5	2010	12873	0.050	Why?
RNA, Messenger	5	2002	6150	0.050	Why?
Pentose Phosphate Pathway	1	2000	69	0.050	Why?
Chromosomes, Human, Pair 19	1	2001	143	0.050	Why?
Proto-Oncogene Proteins c-jun	1	2000	166	0.050	Why?
Enhancer Elements, Genetic	1	2002	467	0.050	Why?
Lipid Peroxidation	1	2000	157	0.050	Why?
Administration, Oral	1	2004	1544	0.050	Why?
Immunoenzyme Techniques	2	2004	1165	0.040	Why?
Insulin Antagonists	1	1979	4	0.040	Why?
Claudin-1	1	2009	32	0.040	Why?
Plasminogen Activator Inhibitor 1	2	1997	65	0.040	Why?
Muscle Proteins	1	2003	549	0.040	Why?
Urokinase-Type Plasminogen Activator	2	1997	136	0.040	Why?
Practice Guidelines as Topic	1	2010	2403	0.040	Why?
Proteins	2	2001	1963	0.040	Why?
Gene Expression Regulation, Plant	1	2019	92	0.040	Why?
Odds Ratio	3	2010	2316	0.040	Why?
CD24 Antigen	1	2009	85	0.040	Why?
Glucocorticoids	3	1979	629	0.040	Why?
Aneuploidy	1	2000	369	0.040	Why?
Molecular Weight	2	1990	629	0.040	Why?
Depression, Chemical	2	2000	52	0.040	Why?
Pregnancy	2	2011	7573	0.040	Why?
Algorithms	4	2010	3890	0.040	Why?
MicroRNAs	1	2012	2947	0.040	Why?
BRCA1 Protein	2	1999	493	0.040	Why?
Leukocyte Count	2	2009	684	0.040	Why?
Hyaluronan Receptors	1	2009	249	0.040	Why?
Randomized Controlled Trials as Topic	4	2009	2594	0.040	Why?
Genome	2	2019	672	0.040	Why?
Risk Factors	10	2010	17523	0.040	Why?
Injections, Intraperitoneal	2	1989	197	0.040	Why?
Aminoglutethimide	1	1997	12	0.040	Why?
Hormone Antagonists	1	1998	101	0.040	Why?
Gene Dosage	2	2008	829	0.040	Why?
Retrospective Studies	10	2009	37905	0.040	Why?
Centrifugation	1	1997	66	0.040	Why?
Cyclins	1	1999	456	0.040	Why?
Breast Neoplasms, Male	1	1998	229	0.040	Why?
Breast	4	2003	1344	0.040	Why?
Epithelium	1	2009	720	0.040	Why?
Testosterone	1	1982	619	0.040	Why?
Neoadjuvant Therapy	6	2006	4975	0.040	Why?
Protein Kinases	2	2008	874	0.040	Why?
Nucleic Acids	2	2012	43	0.040	Why?
Kidney Failure, Chronic	1	2005	960	0.040	Why?
Risk Assessment	4	2010	6869	0.040	Why?
Cisplatin	4	2009	2432	0.040	Why?
Thymidine	3	1982	155	0.040	Why?
Receptor, Insulin	5	1999	97	0.040	Why?
Immunoblotting	2	2004	886	0.030	Why?
Mastectomy, Segmental	2	2004	1026	0.030	Why?
Cytodiagnosis	1	1997	220	0.030	Why?
Protein Kinase Inhibitors	1	2011	4757	0.030	Why?
Proto-Oncogene Proteins c-akt	2	2008	2054	0.030	Why?
Reverse Transcriptase Polymerase Chain Reaction	3	2009	3639	0.030	Why?
Hydrocortisone	1	1997	388	0.030	Why?
Cell Membrane	1	2009	850	0.030	Why?
DNA Replication	2	1989	744	0.030	Why?
Interphase	2	1987	145	0.030	Why?
DNA Primers	4	1999	1399	0.030	Why?
Leukopenia	3	1985	151	0.030	Why?
Down-Regulation	3	2005	2074	0.030	Why?
Chromosomal Proteins, Non-Histone	1	1997	362	0.030	Why?
Quality-Adjusted Life Years	1	1996	226	0.030	Why?
Patient Selection	3	2009	2055	0.030	Why?
Recombinant Proteins	2	1991	2927	0.030	Why?
Azacitidine	1	2001	1149	0.030	Why?
Salvage Therapy	1	2003	2054	0.030	Why?
Cytoplasm	2	1995	652	0.030	Why?
Telomerase	1	1997	525	0.030	Why?
Neoplasms	6	2012	15193	0.030	Why?
Culture Media, Conditioned	1	1994	260	0.030	Why?
Stimulation, Chemical	1	1994	97	0.030	Why?
Isomerism	1	1994	63	0.030	Why?
Hyperplasia	3	2005	557	0.030	Why?
Follicle Stimulating Hormone	1	1994	241	0.030	Why?
Drug Synergism	2	2008	1313	0.030	Why?
Age Factors	3	2007	5377	0.030	Why?
Hematologic Tests	1	1994	82	0.030	Why?
Lymphoma, Large B-Cell, Diffuse	4	1983	1664	0.030	Why?
Societies, Medical	2	2010	1335	0.030	Why?
Neoplasm Staging	6	2007	13658	0.030	Why?
Polyethylene Glycols	1	1997	615	0.030	Why?
Clone Cells	3	1985	555	0.030	Why?
Chromosome Deletion	1	1998	1005	0.030	Why?
Cell Survival	3	1989	3045	0.030	Why?
Vitamin E Deficiency	1	1973	4	0.030	Why?
Peroxides	1	1973	12	0.030	Why?
Antimetabolites, Antineoplastic	3	2009	1299	0.030	Why?
Castration	3	1985	122	0.030	Why?
Cell Movement	1	2001	2466	0.030	Why?
Methemoglobinemia	1	1973	18	0.030	Why?
Chi-Square Distribution	1	1996	1323	0.030	Why?
Hemolysis	1	1973	127	0.030	Why?
Cloning, Molecular	2	1993	1213	0.030	Why?
Mammography	2	2010	1010	0.030	Why?
Quality Control	1	1993	457	0.030	Why?
Protein Biosynthesis	1	1996	889	0.030	Why?
RNA Stability	1	2012	125	0.030	Why?
Male	15	2005	123000	0.030	Why?
Erythrocytes	1	1973	339	0.030	Why?
Antisense Elements (Genetics)	1	1991	18	0.030	Why?
Electrophoresis, Agar Gel	1	1991	82	0.030	Why?
Templates, Genetic	1	1991	86	0.020	Why?
Phosphatidylinositol 3-Kinases	1	2008	1678	0.020	Why?
TOR Serine-Threonine Kinases	1	2008	1546	0.020	Why?
Cytochrome P-450 CYP2B6	1	2010	22	0.020	Why?
Inactivation, Metabolic	1	2010	37	0.020	Why?
Sex Hormone-Binding Globulin	1	2010	40	0.020	Why?
Medical Oncology	2	2010	1423	0.020	Why?
DNA Damage	1	1999	1954	0.020	Why?
Oxidoreductases, N-Demethylating	1	2010	41	0.020	Why?
Rats	6	2000	6086	0.020	Why?
Glutathione S-Transferase pi	1	2010	69	0.020	Why?
DNA Methylation	1	2001	2669	0.020	Why?
Aryl Hydrocarbon Hydroxylases	1	2010	78	0.020	Why?
Base Sequence	4	2000	4917	0.020	Why?
Diethylstilbestrol	1	1990	109	0.020	Why?
Cytochrome P-450 CYP3A	1	2010	83	0.020	Why?
Alanine	1	1991	240	0.020	Why?
Insulin Receptor Substrate Proteins	2	2001	132	0.020	Why?
Orchiectomy	1	1990	214	0.020	Why?
False Negative Reactions	1	2010	275	0.020	Why?
Burnout, Professional	1	1993	205	0.020	Why?
Uridine	2	1980	59	0.020	Why?
Dexamethasone	3	1980	1450	0.020	Why?
False Positive Reactions	1	2010	355	0.020	Why?
Buserelin	1	1989	1	0.020	Why?
Lipid Metabolism	1	1973	483	0.020	Why?
Endometrial Neoplasms	1	1998	1341	0.020	Why?
Remission Induction	2	1998	3569	0.020	Why?
Mutation	4	2003	15179	0.020	Why?
Cell Transformation, Neoplastic	2	1998	2359	0.020	Why?
Affinity Labels	1	1988	28	0.020	Why?
Carcinoma in Situ	1	1992	487	0.020	Why?
Solubility	1	1989	242	0.020	Why?
Bone Density Conservation Agents	1	2010	198	0.020	Why?
Membrane Proteins	1	2009	2819	0.020	Why?
Biological Availability	1	1989	214	0.020	Why?
Primary Prevention	1	2010	255	0.020	Why?
Recurrence	3	2009	4758	0.020	Why?
Up-Regulation	2	2005	2450	0.020	Why?
Gene Expression Regulation	3	1998	4053	0.020	Why?
Chromosome Aberrations	1	1995	1960	0.020	Why?
Microfilament Proteins	2	2003	487	0.020	Why?
Patient Care Team	1	1993	795	0.020	Why?
Karyotyping	2	1987	1022	0.020	Why?
CHO Cells	2	2000	311	0.020	Why?
Carcinoma, Intraductal, Noninfiltrating	1	1992	674	0.020	Why?
Culture Techniques	2	1978	132	0.020	Why?
Linear Models	1	1990	1085	0.020	Why?
3T3 Cells	2	2000	355	0.020	Why?
Agar	1	1987	26	0.020	Why?
Choline Dehydrogenase	1	2006	2	0.020	Why?
Cricetinae	2	2000	706	0.020	Why?
Palliative Care	1	1998	2037	0.020	Why?
Gene Frequency	1	2010	1163	0.020	Why?
Cohort Studies	3	2006	9244	0.020	Why?
Fatty Acids	3	1983	448	0.020	Why?
Receptors, Interleukin-17	1	2006	20	0.020	Why?
Cell Adhesion	1	1989	1008	0.020	Why?
Research Design	2	2005	1544	0.020	Why?
Xenograft Model Antitumor Assays	2	2008	3821	0.020	Why?
Microscopy, Electron	1	1987	600	0.020	Why?
Pilot Projects	3	1999	2803	0.020	Why?
Culture Media	2	1984	319	0.020	Why?
Injections, Subcutaneous	1	1987	334	0.020	Why?
Adolescent	3	2005	31252	0.020	Why?
Delayed-Action Preparations	1	1987	208	0.020	Why?
Bone Marrow Transplantation	1	1991	1581	0.020	Why?
Response Elements	1	2006	193	0.020	Why?
Cells, Cultured	7	1987	5637	0.020	Why?
Oncogenes	1	1989	673	0.020	Why?
Bone Neoplasms	3	2000	2576	0.020	Why?
Transforming Growth Factor beta	1	1992	1130	0.020	Why?
Cancer Vaccines	1	2011	697	0.020	Why?
Immunologic Techniques	1	1985	43	0.020	Why?
Health Status Disparities	1	2009	291	0.020	Why?
Biological Products	1	1989	274	0.020	Why?
Adrenalectomy	3	1978	188	0.020	Why?
Tissue Distribution	2	1997	875	0.020	Why?
Sensitivity and Specificity	2	2010	4971	0.020	Why?
Phenylalanine	1	1986	142	0.020	Why?
Ethics, Medical	1	1989	442	0.020	Why?
Nausea	2	1985	525	0.020	Why?
Hematopoietic Stem Cell Transplantation	1	2003	6550	0.020	Why?
Probability	1	2007	866	0.020	Why?
Endpoint Determination	1	2005	176	0.020	Why?
Raloxifene Hydrochloride	1	1985	47	0.020	Why?
Mitosis	1	1987	615	0.020	Why?
Medroxyprogesterone Acetate	1	1985	55	0.020	Why?
Mammary Glands, Human	1	2006	184	0.020	Why?
Random Allocation	4	1989	703	0.020	Why?
Statistics, Nonparametric	1	2007	980	0.020	Why?
Nafoxidine	1	1984	10	0.020	Why?
Phlebitis	1	1984	8	0.020	Why?
Guinea Pigs	1	1984	241	0.020	Why?
Evidence-Based Medicine	1	2010	1085	0.020	Why?
Research Support as Topic	1	2005	122	0.020	Why?
Chemoprevention	1	2005	241	0.020	Why?
Chromatin Immunoprecipitation	1	2005	518	0.020	Why?
Angiogenesis Inhibitors	1	2011	1248	0.020	Why?
Leydig Cell Tumor	1	1983	10	0.010	Why?
Chickens	1	1984	523	0.010	Why?
Confidence Intervals	1	2005	756	0.010	Why?
Growth Hormone	1	1984	226	0.010	Why?
Toremifene	1	2003	8	0.010	Why?
Megestrol Acetate	1	2003	29	0.010	Why?
Thiotepa	1	2003	118	0.010	Why?
Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating)	1	2002	1	0.010	Why?
Rabbits	1	1984	957	0.010	Why?
Dogs	1	2005	1155	0.010	Why?
Editorial Policies	1	2004	87	0.010	Why?
Species Specificity	1	1984	777	0.010	Why?
Culture Media, Serum-Free	1	2002	74	0.010	Why?
Mastectomy, Modified Radical	1	2003	70	0.010	Why?
Bone Resorption	1	1983	138	0.010	Why?
Drug Evaluation, Preclinical	1	1984	503	0.010	Why?
Patient Care Planning	1	2005	297	0.010	Why?
Hypercalcemia	1	1983	137	0.010	Why?
Antibody Specificity	1	2003	334	0.010	Why?
Risk	2	1998	1972	0.010	Why?
Thyroid Hormones	1	2003	111	0.010	Why?
Binding Sites	1	2006	2171	0.010	Why?
Progesterone	1	1985	513	0.010	Why?
Protein Isoforms	1	2004	842	0.010	Why?
Genes, Neoplasm	1	2003	324	0.010	Why?
Acetates	2	1979	105	0.010	Why?
Cause of Death	1	2005	752	0.010	Why?
Hemagglutinins	1	2001	39	0.010	Why?
Chromosomes, Artificial, Yeast	1	2001	40	0.010	Why?
Physical Chromosome Mapping	1	2001	73	0.010	Why?
NM23 Nucleoside Diphosphate Kinases	1	2001	13	0.010	Why?
Anaphylaxis	1	1983	119	0.010	Why?
Expressed Sequence Tags	1	2001	101	0.010	Why?
Genotype	1	2009	4109	0.010	Why?
Chromosomes, Artificial, Bacterial	1	2001	129	0.010	Why?
Menstruation	1	1980	39	0.010	Why?
Case-Control Studies	1	2010	6100	0.010	Why?
Receptors, Glucocorticoid	2	1979	192	0.010	Why?
Antigens, Nuclear	1	2001	119	0.010	Why?
Spinal Cord Compression	1	1982	151	0.010	Why?
Rodentia	1	1980	65	0.010	Why?
Incidence	1	2010	5673	0.010	Why?
Swine	1	1984	1541	0.010	Why?
Reproducibility of Results	1	2010	6009	0.010	Why?
Kaplan-Meier Estimate	1	2009	6207	0.010	Why?
Macromolecular Substances	1	2000	293	0.010	Why?
Luminescent Proteins	1	2000	289	0.010	Why?
COS Cells	1	2000	377	0.010	Why?
Severity of Illness Index	1	2010	4320	0.010	Why?
Liver Neoplasms	3	2003	4557	0.010	Why?
Regression Analysis	2	1998	1546	0.010	Why?
Piperidines	1	1985	1035	0.010	Why?
RNA, Small Interfering	1	2005	2216	0.010	Why?
Cell Count	1	1980	508	0.010	Why?
Reagent Kits, Diagnostic	1	1999	70	0.010	Why?
Mitotic Index	1	1999	162	0.010	Why?
Molecular Probe Techniques	1	1999	46	0.010	Why?
Precipitin Tests	1	1999	329	0.010	Why?
Microsatellite Repeats	1	2001	575	0.010	Why?
Cyclin D1	1	2001	576	0.010	Why?
Blood-Brain Barrier	1	2000	238	0.010	Why?
Analgesics, Opioid	1	1989	1371	0.010	Why?
In Situ Hybridization, Fluorescence	1	2004	2232	0.010	Why?
Estradiol Congeners	1	1978	8	0.010	Why?
Thymidine Kinase	1	1979	193	0.010	Why?
Lipids	1	1983	644	0.010	Why?
Testosterone Congeners	1	1978	26	0.010	Why?
Cell Differentiation	1	1989	4078	0.010	Why?
CpG Islands	1	2001	633	0.010	Why?
Fluoxymesterone	1	1998	9	0.010	Why?
Leucine	1	1980	352	0.010	Why?
Transplantation, Autologous	1	2003	1914	0.010	Why?
Calcium-Calmodulin-Dependent Protein Kinases	1	1999	206	0.010	Why?
Thrombocytopenia	1	1983	846	0.010	Why?
Mortality	1	1980	343	0.010	Why?
Green Fluorescent Proteins	1	2000	694	0.010	Why?
Mutagens	1	1999	187	0.010	Why?
Drug Therapy, Combination	2	1981	2315	0.010	Why?
Antigens, Neoplasm	1	2005	1506	0.010	Why?
Nuclear Receptor Co-Repressor 2	1	1998	47	0.010	Why?
Nucleic Acid Hybridization	1	1999	542	0.010	Why?
Neuromuscular Diseases	1	1998	63	0.010	Why?
Actuarial Analysis	2	1992	159	0.010	Why?
Cyclin-Dependent Kinase Inhibitor p21	1	1999	528	0.010	Why?
DNA, Complementary	1	1999	869	0.010	Why?
Oxygen	2	1973	754	0.010	Why?
Radiotherapy	1	2004	1824	0.010	Why?
Drug Hypersensitivity	1	1998	128	0.010	Why?
Hematologic Diseases	1	1998	242	0.010	Why?
Precancerous Conditions	1	2003	1058	0.010	Why?
Repetitive Sequences, Nucleic Acid	1	1997	362	0.010	Why?
Hydrogen-Ion Concentration	1	1978	585	0.010	Why?
Dactinomycin	1	1976	145	0.010	Why?
Neoplastic Stem Cells	1	1985	1443	0.010	Why?
Protein Structure, Tertiary	1	2000	1487	0.010	Why?
Epithelial Cells	1	2003	1818	0.010	Why?
Lung Neoplasms	3	2003	11538	0.010	Why?
Genetic Predisposition to Disease	1	2010	5539	0.010	Why?
Ascites	1	1997	198	0.010	Why?
Breast Diseases	1	1998	201	0.010	Why?
Temperature	1	1978	506	0.010	Why?
Mitomycin	1	1997	208	0.010	Why?
Receptors, Androgen	2	1979	878	0.010	Why?
Cell Fractionation	1	1995	68	0.010	Why?
Mice, Transgenic	1	2003	4143	0.010	Why?
Aging	1	1984	1582	0.010	Why?
Metaphase	1	1995	107	0.010	Why?
Income	1	1996	222	0.010	Why?
Genes, Reporter	1	1998	798	0.010	Why?
Adenocarcinoma, Mucinous	1	1999	436	0.010	Why?
Buffers	1	1995	44	0.010	Why?
Registries	1	2003	2170	0.010	Why?
Educational Status	1	1996	397	0.010	Why?
Suppositories	1	1994	12	0.010	Why?
Glucose	2	1983	1248	0.010	Why?
Heterozygote	1	1998	1020	0.010	Why?
Lymphoma, Non-Hodgkin	2	1983	1039	0.010	Why?
Receptors, Urokinase Plasminogen Activator	1	1995	107	0.010	Why?
National Institutes of Health (U.S.)	1	1995	208	0.010	Why?
DNA Mutational Analysis	1	2001	2283	0.010	Why?
GRB7 Adaptor Protein	1	1994	4	0.010	Why?
Multicenter Studies as Topic	1	1996	543	0.010	Why?
Pain Measurement	1	1998	953	0.010	Why?
Neoplasms, Multiple Primary	1	1998	551	0.010	Why?
Tomography, Emission-Computed, Single-Photon	1	1995	305	0.010	Why?
Tomography, Emission-Computed	1	1995	310	0.010	Why?
Preoperative Care	1	2000	1529	0.010	Why?
Residence Characteristics	1	1996	348	0.010	Why?
Pleural Effusion, Malignant	1	1995	156	0.010	Why?
Gastrointestinal Diseases	1	1998	589	0.010	Why?
Hemoglobinuria	1	1973	5	0.010	Why?
Intracellular Signaling Peptides and Proteins	1	1999	1265	0.010	Why?
Catalase	1	1973	70	0.010	Why?
Nitrites	1	1973	61	0.010	Why?
Osteosarcoma	1	2000	929	0.010	Why?
Radiotherapy, Adjuvant	1	1998	2231	0.010	Why?
Oligonucleotides, Antisense	1	1993	248	0.010	Why?
Testicular Neoplasms	1	1976	529	0.010	Why?
Sequence Homology, Amino Acid	1	1994	997	0.010	Why?
Heart Diseases	1	1998	732	0.010	Why?
Caenorhabditis elegans	1	1994	268	0.010	Why?
Enzyme-Linked Immunosorbent Assay	1	1995	1489	0.010	Why?
Diet	1	1979	1440	0.010	Why?
Sodium	1	1973	353	0.010	Why?
Atmospheric Pressure	1	1970	8	0.010	Why?
Ultraviolet Rays	1	1973	575	0.010	Why?
Chromosome Mapping	1	1994	1471	0.010	Why?
Aerospace Medicine	1	1970	51	0.010	Why?
Adrenal Glands	1	1970	122	0.010	Why?
Splenectomy	1	1970	158	0.010	Why?
Mass Spectrometry	1	1992	702	0.010	Why?
Blotting, Northern	1	1989	682	0.010	Why?
Ascitic Fluid	1	1988	76	0.010	Why?
Image Processing, Computer-Assisted	1	1995	1648	0.010	Why?
Leukocytes	1	1970	422	0.010	Why?
Spleen	1	1970	676	0.010	Why?
Postoperative Care	1	1992	739	0.000	Why?
Lymphoma, Follicular	2	1983	587	0.000	Why?
Carcinoma, Hepatocellular	1	2000	2027	0.000	Why?
Stress, Physiological	1	1970	492	0.000	Why?
Adrenal Cortex Hormones	1	1970	544	0.000	Why?
Pleural Effusion	1	1988	201	0.000	Why?
Genes, ras	1	1989	667	0.000	Why?
Surveys and Questionnaires	1	1998	5687	0.000	Why?
Proto-Oncogene Proteins c-myc	1	1989	810	0.000	Why?
Alopecia	1	1985	126	0.000	Why?
Autopsy	1	1983	173	0.000	Why?
Vomiting	1	1985	354	0.000	Why?
Endocrine Glands	1	1982	19	0.000	Why?
Infusions, Parenteral	1	1983	191	0.000	Why?
Deoxyglucose	1	1983	115	0.000	Why?
Methods	1	1982	189	0.000	Why?
Autoradiography	1	1982	132	0.000	Why?
Phospholipids	1	1983	177	0.000	Why?
Eggs	1	1979	24	0.000	Why?
Ovarian Neoplasms	1	1995	4638	0.000	Why?
Milk	1	1979	120	0.000	Why?
Cell Separation	1	1981	612	0.000	Why?
Steroids	1	1980	356	0.000	Why?
Dietary Fats	1	1979	339	0.000	Why?
B-Lymphocytes	1	1983	1294	0.000	Why?
Calcium	1	1983	1537	0.000	Why?
Energy Intake	1	1979	515	0.000	Why?
Prolactin	1	1977	155	0.000	Why?
Lactation	1	1977	210	0.000	Why?
Acute Disease	1	1980	2422	0.000	Why?
Androgen Antagonists	1	1977	411	0.000	Why?
Androgens	1	1977	511	0.000	Why?
Heart Failure	1	1985	2516	0.000	Why?
T-Lymphocytes	1	1983	3869	0.000	Why?
Child	1	1983	29154	0.000	Why?

OSBORNE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (714)

Explore

Co-Authors (18)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors